NASDAQ
Neuphoria Therapeutics Inc. (NEUP) has a revenue compound annual growth rate of 244.91% over 5 years and 11.90% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.